No Data
Returns At Calumet (NASDAQ:CLMT) Are On The Way Up
Goldman Sachs Maintains Calumet Partners(CLMT.US) With Buy Rating, Raises Target Price to $22
Goldman Sachs analyst Neil Mehta maintains $Calumet Partners(CLMT.US)$ with a buy rating, and adjusts the target price from $17 to $22.According to TipRanks data, the analyst has a success rate of 61.
Calumet Up Over 17%, on Track for Highest Close Since December 2015 -- Data Talk
Zoom Video Posts Strong Q2 Results, Joins Peloton Interactive, Opera And Other Big Stocks Moving Higher On Thursday
Calumet to Attend Barclays 38th Annual CEO Energy-Power Conference
Calumet, Inc. (NASDAQ:CLMT) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?